Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
NCT01647906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 277
Last updated 2019-11-25
Summary
The purpose of this observational study is to evaluate the safety and effectiveness of the Solesta Injectable Bulking Agent in the treatment of fecal incontinence through 3 years in a real world setting.
Conditions
- Fecal Incontinence
Sponsors & Collaborators
-
Bausch Health Americas, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2018-09-15
- Completion
- 2018-09-15
Countries
- United States
Study Locations
More Related Trials
-
Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
NCT01263574 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
NCT03649477 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Clinical Investigation to Evaluate the Safety and Effectiveness of Juläine™ in Improving Gluteal Skin Laxity in Adults.
NCT07332650 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients
NCT06448143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence
NCT02292628 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NCT03530852 ·Status: RECRUITING ·Phase: NA
-
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
NCT05535361 ·Status: RECRUITING ·Phase: NA
-
The Surrogate Project (Surrogate Storytelling)
NCT01902784 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Iron Sucrose in Children
NCT00239642 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex Dose Finding Under Two Years Old
NCT06575036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence
NCT01380132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
NCT04609943 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of LEAF-4L6715 for Acute Respiratory Distress Syndrome
NCT06640777 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Lipid Infusion in Dialysis Patients With Endotoxemia
NCT00506454 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
NCT03723564 ·Status: RECRUITING ·Phase: PHASE1
-
Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
NCT01637272 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of FDY-5301 in Major Trauma Patients in ICU
NCT04430283 ·Status: TERMINATED ·Phase: PHASE2
-
Sayana-Uniject Volumetric Delivery
NCT01298479 ·Status: COMPLETED
-
Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
NCT01161641 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study in Infant With SBS
NCT02865122 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.
NCT04641364 ·Status: COMPLETED ·Phase: PHASE1
-
Polyacrylamide Injection in Patients Ineligible for Surgery
NCT02776423 ·Status: COMPLETED
-
3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency
NCT04228445 ·Status: COMPLETED ·Phase: PHASE3